CD8A and neoplasm: The presence of IL2 in tumor tissues promoted the proliferation of the CD8+ T and NK cells to suppress tumor growth, resulting in a 68% tumor inhibitory rate in a subcutaneous 4T1 tumor-bearing mouse model.